Flonoltinib not checked

Chengdu Zenitar Biomedical Technology Co., Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
6 active
9 in total
Targets
 

What this is

How it works
Blocks a kinase, an enzyme that passes "grow" or "activate" signals inside cells. Most are cancer drugs.-tinib: tyrosine kinase inhibitors WHO name stem
How it’s given
“Flonoltinib Maleate Tablet 100mg, oral administration, once daily, given on an empty stomach for 8 consecutive weeks of treatment.”In the company’s words, NCT07232290 on ClinicalTrials.gov
Tested for
MF (2 trials), MF,PMF,PPV-MF,PET-MF, Polycythemia Vera (PV), Myelofibrosis, Myelofibrosis Due to and Following Polycythemia Vera, Myelofibrosis Transformation in Essential Thrombocythemia, Myelofibrosis With High Molecular Risk Mutations, Myelofibrosis With Myeloid Metaplasia and 8 more
Main trialPhase 3
“This trial adopts a multicenter, open label, positive drug parallel controlled clinical trial design, with a planned enrollment of approximately 105 participants in the MF trial. Successful trial participants were selected and assigned to either the experimental group or the control group in a 2:1 stratified manner, with the stratification factor being the Dynamic International Prognostic Scoring System (DIPSS) prognostic grading criteria. Continuously take the test drug/control drug until it meets the withdrawal criteria.”In the company’s words, NCT07317700 on ClinicalTrials.gov

Other drugs for MF

All 265 drugs for MF

Coming up5

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Dec 2027 A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
Phase 2Active, not recruiting 26 Nov 2025 A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
Phase 2Recruiting 30 Jul 2027 Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
Phase 2Recruiting 30 Dec 2027 A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Intermediate to High Risk Myelofibrosis
Phase 2Not yet recruiting Nov 2028 Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis
Phase 1Not yet recruiting 30 Dec 2026 Clinical Study on Drug Interactions of Flonoltinib Maleate Tablets
Phase 1/2Completed 29 Nov 2023 Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative
Phase 1Completed 15 Aug 2024 A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects
Phase 1Completed 25 Jul 2026 Mass Balance Study of [14C] Flonoltinib Maleate
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Flonoltinib

Following is part of Solo: you see every change to Flonoltinib the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in